|
Daniel has an extensive scientific and medical background, as well as seasoned experience in raising capital in today’s competitive tech market. Henderson, former president and CEO of San Diego-based Arizeke Pharmaceuticals, has helped raise more than $40 million for two life science companies, Calydon, Inc. and Microgenics Corp. He sold Microgenics in 1992 diagnostics giant Boehringer-Mannheim for $60 million. Boehringer-Mannheim is now part of pharmaceutical leader Roche. Henderson who invented the ARCA family of anti-cancer therapeutics while at Calydon has been a visiting scholar at Stanford University Medical Center. He holds a Bachelor’s Degree from UC Berkeley and a Ph.D. from the University of New Mexico Medical Center. He was a postdoctoral fellow at Duke University Medical Center. | 